Long-term treatment persistence and maintained reduction of LDL-cholesterol levels with evolocumab over 30 months: Results from the Spanish cohort of the European prospective HEYMANS study

Authors :: Agustín Blanco Echevarría
Juan De Dios García Díaz
Assumpta Caixas
Núria Plana Gil
Miguel Ángel Rico Corral
Ian Bridges
Nafeesa Dhalwani
Sònia Gatell Menchen
Kausik K. Ray
Source :: Clínica e Investigación en Arteriosclerosis.
Publication Year :: 2023
Publisher :: Elsevier BV, 2023.

Tools